An Act relating to covered entity reporting to increase accountability to safeguard benefit for vulnerable patients
By Mr. Cronin, a petition (accompanied by bill, Senate, No. 848) of John J. Cronin for legislation to require all covered entities to file an annual report to the Center for Health Information and Analysis to increase accountability to safeguard benefit for vulnerable patients. Health Care Financing.
This bill requires that, beginning on April 1, 2026, entities participating in the federal 340B drug pricing program in Massachusetts must submit an annual report to the Center for Health Information and Analysis. This report should include comprehensive financial and operational data, such as the aggregate acquisition costs for covered outpatient drugs, insurer payments, and the total number and percentage of prescriptions filled by insurance type. Entities must also disclose total operating costs, highlighting those related to passing 340B discounts to patients, implementing sliding fee scales for low-income individuals, and providing charity care. Additionally, the report must detail payments to contract pharmacies and third parties for 340B services and list the number and locations of contract pharmacies.
The report should also cover prescriptions filled by the entity and any offsite facilities, the proportion processed by contract pharmacies, and related remuneration for 340B services. An officer must certify the accuracy and completeness of these reports, ensuring transparency and accountability. The Center will make these reports publicly accessible on its website. The act, aiming to increase transparency and oversight of the 340B program, takes effect immediately upon passage.
The information contained in this website is for general information purposes only. The General Court provides this information as a public service and while we endeavor to keep the data accurate and current to the best of our ability, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.